SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-019952
Filing Date
2021-04-02
Accepted
2021-04-02 16:15:59
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea138661-s3_citiuspharma.htm S-3 531074
2 FORM OF INDENTURE ea138661ex4-29_citiuspharma.htm EX-4.29 378993
3 OPINION OF WYRICK ROBBINS YATES & PONTON, LLP ea138661ex5-1_citiuspharma.htm EX-5.1 31803
4 CONSENT OF WOLF & COMPANY, P.C ea138661ex23-1_citiuspharma.htm EX-23.1 1596
5 GRAPHIC image_001.jpg GRAPHIC 13550
6 GRAPHIC ex5-1_001.jpg GRAPHIC 2360
  Complete submission text file 0001213900-21-019952.txt   966822
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-255005 | Film No.: 21802145
SIC: 2834 Pharmaceutical Preparations